Gland Pharma IPO
Gland Pharma is one of the fastest-growing generic injectable-focused firms, marketing its drugs in over 60 markets including the United States, Europe, Canada, Australia, India and the rest of the world, mainly under a B2B model. In India, Gland Pharma has seven manufacturing facilities with a capacity of approx. 750 million units. This consists of 4 manufacturing facilities having 22 production lines and 3 API manufacturing facilities. Incorporated in Hyderabad, India in 1978, the company has a business presence in the segments of sterile injectables, oncology & ophthalmic and focuses on complex injectable products including NCE-1s, First to File products. & 505(b)(2) filings. The company products are delivered via liquid vials, pre-filled syringes, ampoules, bags, and lyophilized vials. The company has been putting efforts to expand by adding manufacturing capabilities in injectables like peptides, long acting injectables, suspensions & hormonal products.
The company focuses on meeting needs in the injectables segment by offering high-quality products at attractive rates. It has been using its R&D expertise & competent management to produce quality products for the world markets.
Company Strengths
- Extensive processing capacities of complex injectables with a good compliance track record.
- B2B-led diversified platform across markets, along with a targeted B2C model in India.
- Extensive range of complex products backed with good R&D and regulatory capabilities.
- The company has a good track record of growth and profitability from a diversified base of sales.
- The company has a well experienced & qualified management team.
Gland Pharma IPO Registrar-
Link Intime India Private Limited
C-101, 1st Floor, 247 Park Lal Bahadur Shastri Marg, Vikhroli (West)
Mumbai – 400 083
Phone: +91 22 4918 6200
Fax: +91 22 4918 6195
Email: glandpharma.ipo@linkintime.co.in
Website: http://www.linkintime.co.in
Gland Pharma Company Details-
Gland Pharma Limited
Sy. No. 143 – 148, 150 and 151,
Near Gandi Maisamma ‘X’ Roads,
D.P. Pally, Dundigal,
Dundigal – Gandi Maisamma (M),
Medchal-Malkajgiri District,
Hyderabad 500 043
Phone: +91 40 3051 0999
Email: investors@glandpharma.com
Website: www.glandpharma.com
Also Read: Mrs. Bectors Food Specialities Limited IPO: Purpose Financial Performance, Valuation
Financials of Gland Pharma
| Particulars | 30 June 2020 (in INR Million) | 31 March 2020 (in INR Million) | 31 March 2019 (in INR Million) | 31 March 2018 (in INR Million) |
| Total Assets | 46,912.65 | 40,860.39 | 35,235.49 | 29,294.68 |
| Total Revenue | 9,162.89 | 27,724.08 | 21,297.67 | 16,716.82 |
| Profit after Tax | 3,135.90 | 7,728.58 | 4,518.56 | 3,210.51 |
Details
| Date of IPO | 9th November 2020 to 11th November 2020 |
| Type of Issue | Book Built Issue IPO |
| Size of Issue | 43,196,968 Equity Shares of ₹1 aggregating up to ₹6,479.55 Crores |
| Fresh Issue | 8,333,333 Eq Shares of ₹1 summing up to ₹1,250.00 Crores |
| Offer for sale | 34,863,635 Equity Shares of ₹1 accumulating up to ₹5,229.55 Crores |
| Face value | ₹1/equity share |
| IPO Price | ₹1490 to ₹1500 for 1 equity share |
| Market Lot | 10 shares |
| Minimum Order Quantity | 10 Shares |
| Listing | NSE, BSE |
| Retail Allocation | 35% |
Gland Pharma IPO Tentative Schedule
| Bid/Offer Open date | 9 November 2020 |
| Bid/Offer Close Date | 11 November 2020 |
| Finalisation on basis of allotment date | 17 November 2020 |
| Refunds Initiation date | 18 November 2020 |
| Credit of shares to Demat Account | 19 November 2020 |
| Listing date of IPO Shares | 20 November 2020 |
Gland Pharma IPO Lot Size & Price for Retail Investors
| Application Size | Lots | Shares | Amount |
| Minimum | 1 | 10 | 15,000 INR |
| Maximum | 13 | 130 | 1,95,000 INR |
Frequently Asked Questions (FAQs)
1. How to apply for an IPO for Gland Pharma?
You may apply for Gland Pharma IPO online through any broking platform either by UPI or ASBA as a payment form. The ASBA IPO application is available via your bank account's net banking framework. UPI IPO application is supported by dealers that do not have banking services.
2. What is the lot size for the IPO of Gland Pharma?
The Gland Pharma IPO has a lot of 10 shares. And Retail investors can bid for a maximum of 13 lots.
3. What is the price band for Gland Pharma IPO?
The price band for Gland Pharma IPO is Rs.1490- Rs.1500 for an equity share.
4. What is the listing date for the IPO shares of Gland Pharma?
The Gland Pharma IPO Shares will be listed on 20 November 2020.
5. How to use UPI to pay for the Gland Pharma IPO?
You'll have to pay using UPI-supported BHIM or GPay if your broker doesn't provide banking services. Link your bank account to your UPI platform. A payment order to complete your bid for Gland Pharma IPO on your UPI platform will be issued. Then, accept the request for making payment to block your bid.
6. How will I get the IPO Shares from Gland Pharma?
The shares will be credited directly to your DEMAT account after the allotment is finalised.